This session showcases the outcomes of ten ESR Research Seed Grant projects, promoting advancements in the fields of contrast-enhanced imaging and imaging surveillance in cancer treatment. It introduces the ESR Research Seed Grant funding scheme, a programme aiming to stimulate innovative projects and pilot studies to propel them towards larger research efforts and further funding applications.
Introduction
Regina G. H. Beets-Tan, Amsterdam / Netherlands
Marion Smits, Rotterdam / Netherlands
SeqSynth: synthetic neuro-oncological post-contrast sequence synthesis by deep generative modelling
James Kelsey K Ruffle, Hemel Hempstead / United Kingdom
Utilizing Deep Learning for Opportunistic Cardiac Output Estimation from Bolus-Tracking Data
Mario Laudazi, Roma / Italy
Sustainable Iodine Contrast Media for a Healthy Future
Andrew England, Cork / Ireland
Updated assessment of MR Perfusion in the context of "RANO 2.0". Precision discrimination of disease progression, depending on the molecular profile of gliomas
Loizos Siakallis, Nicosia / Cyprus
A new fast DWI-based MR protocol for surveillance in patients with a high risk of ovarian cancer recurrence during PARP-inhibitors maintenance to enhance secondary cytoreduction results
Giacomo Avesani, Rome / Italy
Intra-arterial Computed Tomography liver perfusion (IA CT liver perfusion) as an aid for dose planning of colorectal liver metastasis (mCRC)
Charlotte Schneider, Amsterdam / Netherlands
AI-facilitated detection of mesenteric involvement in ovarian cancer and its impact on patient outcome
Camilla Panico, Rome / Italy
Surveillance Without Contrast - Diagnostic Effectiveness of SMI Ultrasound in Detecting Endoleaks after EVAR
Marcin Czeczelewski, Lublin / Poland
Longitudinal Assessment of Renal Allografts in Donor-Recipient Pairs by Perfusion Quantification Using Arterial Spin Labeling (ASL-MRI)
Tijana Radovic, Belgrade / Serbia
Blood-Brain Barrier Dysfunction as a Marker of Tissue Fate in Cerebral Venous Thrombosis
Sara Botelho Rosa, Lisbon / Portugal